Scott Gottlieb
The FDA awarded more than $18 million in grants over the next 4 years to fund clinical trials of medical products intended to treat patients with rare diseases.
“Developing a treatment for a rare disease can be especially challenging. Given the often small number of patients affected by certain very rare diseases, there can be limited markets for new treatments and — as a result — fewer resources devoted to researching these opportunities,” FDA Commissioner Scott Gottlieb, MD, said in a press release. “The FDA is committed to (Read more...)
Uncategorized